Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese women (original) (raw)

References

  1. Ridker PM . Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363–369.
    Article PubMed Google Scholar
  2. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB . Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.
    Article CAS PubMed Google Scholar
  3. Piéroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C . Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab 2003; 29: 133–138.
    Article PubMed Google Scholar
  4. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC . Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179–1186.
    Article CAS PubMed Google Scholar
  5. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F . Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99: 2221–2222.
    Article CAS PubMed Google Scholar
  6. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.
    Article CAS PubMed Google Scholar
  7. Maruna P, Gurlich R, Frasko R, Haluzik M . Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI. Physiol Res 2001; 50: 589–594.
    CAS PubMed Google Scholar
  8. Bullo M, Garcia-Lorda P, Megias I, Sals-Salvado J . Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11: 525–531.
    Article CAS PubMed Google Scholar
  9. Benedek IH, Blouin RA, McNamara PJ . Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. Br J Clin Pharmacol 1984; 18: 941–946.
    Article CAS PubMed PubMed Central Google Scholar
  10. Pickup JC, Mattock MB, Chusney GD, Burt D . NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–1292.
    Article CAS PubMed Google Scholar
  11. Hanusch-Enserer U, Cauza E, Spak M, Dunky A, Rosen HR, Wolf H, Prager R, Eibl MM . Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 2003; 27: 355–361.
    Article CAS PubMed Google Scholar
  12. Bastard JP, Vidal H, Jardel C, Bruckert E, Robin D, Vallier P, Blondy P, Turpin G, Forest C, Hainque B . Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects. Int J Obes Relat Metab Disord 2000; 24: 70–74.
    Article CAS PubMed Google Scholar
  13. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B . Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338–3342.
    CAS PubMed Google Scholar
  14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR . Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557–1565.
    Article CAS PubMed Google Scholar
  15. Ridker PM, Buring JE, Cook NR, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003; 107: 391–397.
    Article PubMed Google Scholar
  16. Gomez-Ambrosi J, Salvador J, Paramo JA, Orbe J, de Irala J, Diez-Caballero A, Gil MJ, Cienfuegos JA, Fruhbeck G . Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 2002; 35: 315–320.
    Article CAS PubMed Google Scholar
  17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.
    Article CAS PubMed PubMed Central Google Scholar
  18. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–1830.
    Article CAS PubMed PubMed Central Google Scholar
  19. Bastard JP, Maachi M, Tran Van Nhieu J, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B . Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002; 87: 2084–2089.
    Article CAS PubMed Google Scholar
  20. Hotamisligil GS . Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000; 24 (Suppl 4): S23–S27.
    Article CAS PubMed Google Scholar
  21. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M . Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003; 311: 372–379.
    Article CAS PubMed Google Scholar
  22. Fain JN, Cheema PS, Bahouth SW, Hiler ML . Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2002; 300: 674–678.
    Article Google Scholar
  23. Pasceri V, Willerson JT, Yeh ET . Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165–2168.
    Article CAS PubMed Google Scholar
  24. Yeh ET, Anderson HV, Pasceri V, Willerson JT . C-reactive protein: linking inflammation to cardiovascular complications. Circulation 2001; 104: 974–975.
    Article CAS PubMed Google Scholar
  25. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA . Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105: 1890–1896.
    Article CAS PubMed Google Scholar
  26. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S . C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783–1790.
    Article CAS PubMed Google Scholar
  27. Heilbronn LK, Noakes M, Clifton PM . Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Artrioscler Thromb Vasc Biol 2001; 21: 968–970.
    Article CAS Google Scholar
  28. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET . Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002; 105: 564–569.
    Article PubMed Google Scholar
  29. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D . Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–809.
    Article CAS PubMed Google Scholar
  30. Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G . Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042–1047.
    Article CAS PubMed Google Scholar
  31. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–1804.
    Article CAS PubMed Google Scholar

Download references